My NCBI | Sign In
RSS Settings
  • Search: Digenio AG[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 17

    1.

    Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trial.

    Digenio AG, Mancuso JP, Gerber RA, Dvorak RV.

    Ann Intern Med. 2009 Feb 17;150(4):255-62.PMID: 19221377 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism.

    Brousseau ME, Millar JS, Diffenderfer MR, Nartsupha C, Asztalos BF, Wolfe ML, Mancuso JP, Digenio AG, Rader DJ, Schaefer EJ.

    J Lipid Res. 2009 Jul;50(7):1456-62. Epub 2009 Feb 3.PMID: 19193611 [PubMed - in process]Related articles

    3.

    Health-risk appraisal with or without disease management for worksite cardiovascular risk reduction.

    Maron DJ, Forbes BL, Groves JR, Dietrich MS, Sells P, DiGenio AG.

    J Cardiovasc Nurs. 2008 Nov-Dec;23(6):513-8.PMID: 18953215 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism.

    Millar JS, Brousseau ME, Diffenderfer MR, Barrett PH, Welty FK, Cohn JS, Wilson A, Wolfe ML, Nartsupha C, Schaefer PM, Digenio AG, Mancuso JP, Dolnikowski GG, Schaefer EJ, Rader DJ.

    J Lipid Res. 2008 Mar;49(3):543-9. Epub 2007 Nov 21.PMID: 18033754 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.

    Millar JS, Brousseau ME, Diffenderfer MR, Barrett PH, Welty FK, Faruqi A, Wolfe ML, Nartsupha C, Digenio AG, Mancuso JP, Dolnikowski GG, Schaefer EJ, Rader DJ.

    Arterioscler Thromb Vasc Biol. 2006 Jun;26(6):1350-6. Epub 2006 Mar 30.PMID: 16574893 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.

    Brousseau ME, Diffenderfer MR, Millar JS, Nartsupha C, Asztalos BF, Welty FK, Wolfe ML, Rudling M, Björkhem I, Angelin B, Mancuso JP, Digenio AG, Rader DJ, Schaefer EJ.

    Arterioscler Thromb Vasc Biol. 2005 May;25(5):1057-64. Epub 2005 Mar 10.PMID: 15761191 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Evaluation of methods for improving precision of blood pressure measurements in phase I clinical trials.

    Terra SG, Blum RA, Wei GC, Lew RA, Digenio AG, Rajman I, Kazierad DJ.

    J Clin Pharmacol. 2004 May;44(5):457-63.PMID: 15102865 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol.

    Brousseau ME, Schaefer EJ, Wolfe ML, Bloedon LT, Digenio AG, Clark RW, Mancuso JP, Rader DJ.

    N Engl J Med. 2004 Apr 8;350(15):1505-15.PMID: 15071125 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effect of myocardial ischaemia on left ventricular function and adaptability to exercise training.

    Digenio AG, Noakes TD, Joughin H, Daly L.

    Med Sci Sports Exerc. 1999 Aug;31(8):1094-101.PMID: 10449009 [PubMed - indexed for MEDLINE]Related articles

    10.

    Ventilatory responses to exercise in patients with asymptomatic left ventricular dysfunction.

    Digenio AG, Noakes TD, Joughin H, Daly L.

    Med Sci Sports Exerc. 1999 Jul;31(7):942-8.PMID: 10416554 [PubMed - indexed for MEDLINE]Related articles

    11.

    Physiological benefits of a prolonged moderate-intensity endurance training programme in patients with coronary artery disease.

    Joughin HM, Digenio AG, Daly L, Kgare E.

    S Afr Med J. 1999 May;89(5):545-50.PMID: 10416459 [PubMed - indexed for MEDLINE]Related articles

    12.

    Should all cardiac patients be offered the choice of cardiac rehabilitation?

    Digenio AG, Joughin HM.

    S Afr Med J. 1997 Jun;87 Suppl 3:C136-44. Review.PMID: 9254764 [PubMed - indexed for MEDLINE]Related articles

    13.

    Predictors of exercise capacity and adaptability to training in patients with coronary artery disease.

    Digenio AG, Noakes TD, Cantor A, Groeneveld H, Daly L, Mavunda D, Esser JD.

    J Cardiopulm Rehabil. 1997 Mar-Apr;17(2):110-20.PMID: 9101388 [PubMed - indexed for MEDLINE]Related articles

    14.

    Is severe left ventricular dysfunction a contraindication to participation in an exercise rehabilitation programme?

    Digenio AG, Cantor A, Noakes TD, Cloete L, Mavunda D, Esser JD.

    S Afr Med J. 1996 Sep;86(9):1106-9.PMID: 8888780 [PubMed - indexed for MEDLINE]Related articles

    15.

    Multivariate models for compliance with phase 3 cardiac rehabilitation services in Johannesburg.

    Digenio AG, Padayachee N, Groeneveld H.

    Ann Acad Med Singapore. 1992 Jan;21(1):121-7.PMID: 1590645 [PubMed - indexed for MEDLINE]Related articles

    16.

    Exercise-related cardiac arrest in cardiac rehabilitation. The Johannesburg experience.

    Digenio AG, Sim JG, Dowdeswell RJ, Morris R.

    S Afr Med J. 1991 Feb 16;79(4):188-91.PMID: 1996434 [PubMed - indexed for MEDLINE]Related articles

    17.

    The Johannesburg cardiac rehabilitation programme.

    Digenio AG, Sim JG, Krige K, Stewart A, Morris R, Dowdeswell RJ, Padayachee GN.

    S Afr Med J. 1991 Feb 16;79(4):183-7.PMID: 1996433 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Search details

    » See more...

    Recent activity